515 related articles for article (PubMed ID: 34226206)
1. Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data.
Hedberg P; Karlsson Valik J; van der Werff S; Tanushi H; Requena Mendez A; Granath F; Bell M; Mårtensson J; Dyrdak R; Hertting O; Färnert A; Ternhag A; Naucler P
Thorax; 2022 Feb; 77(2):154-163. PubMed ID: 34226206
[TBL] [Abstract][Full Text] [Related]
2. Wastewater concentrations of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus, rhinovirus, and seasonal coronavirus nucleic-acids during the COVID-19 pandemic: a surveillance study.
Boehm AB; Hughes B; Duong D; Chan-Herur V; Buchman A; Wolfe MK; White BJ
Lancet Microbe; 2023 May; 4(5):e340-e348. PubMed ID: 36965504
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of mortality in patients admitted with an infection with influenza A/B virus, respiratory syncytial virus, rhinovirus, metapneumovirus or SARS-CoV-2.
Boon H; Meinders AJ; van Hannen EJ; Tersmette M; Schaftenaar E
Influenza Other Respir Viruses; 2024 Jan; 18(1):e13237. PubMed ID: 38249443
[TBL] [Abstract][Full Text] [Related]
4. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
[TBL] [Abstract][Full Text] [Related]
5. Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021.
Perez A; Lively JY; Curns A; Weinberg GA; Halasa NB; Staat MA; Szilagyi PG; Stewart LS; McNeal MM; Clopper B; Zhou Y; Whitaker BL; LeMasters E; Harker E; Englund JA; Klein EJ; Selvarangan R; Harrison CJ; Boom JA; Sahni LC; Michaels MG; Williams JV; Langley GE; Gerber SI; Campbell A; Hall AJ; Rha B; McMorrow M;
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1253-1259. PubMed ID: 36201373
[TBL] [Abstract][Full Text] [Related]
6. Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain.
Ambrosch A; Luber D; Klawonn F; Kabesch M
J Clin Virol; 2023 Apr; 161():105399. PubMed ID: 36863135
[TBL] [Abstract][Full Text] [Related]
7. Cycle threshold dynamics of non-severe acute respiratory coronavirus virus 2 (SARS-CoV-2) respiratory viruses.
Ehrenzeller S; Zaffini R; Pecora ND; Kanjilal S; Rhee C; Klompas M
Infect Control Hosp Epidemiol; 2024 May; 45(5):630-634. PubMed ID: 38234188
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.
Hashemi SA; Safamanesh S; Ghasemzadeh-Moghaddam H; Ghafouri M; Azimian A
J Med Virol; 2021 Feb; 93(2):1008-1012. PubMed ID: 32720703
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of SARS-CoV-2 Omicron Variant Infections Compared With Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicenter Cohort Study.
Hedberg P; Karlsson Valik J; Abdel-Halim L; Alfvén T; Nauclér P
Clin Infect Dis; 2024 Apr; 78(4):900-907. PubMed ID: 37883521
[TBL] [Abstract][Full Text] [Related]
10. The disappearance of respiratory syncytial virus and influenza viruses in children during the second year of the COVID-19 pandemic - are non-pharmaceutical interventions as effective as vaccines?
Kışlal FM; Hanilçe Y; Altaş B; Büyükbaşaran ZE; Güven D
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3777-3783. PubMed ID: 37140326
[TBL] [Abstract][Full Text] [Related]
11. Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study.
Moso MA; Taiaroa G; Steinig E; Zhanduisenov M; Butel-Simoes G; Savic I; Taouk ML; Chea S; Moselen J; O'Keefe J; Prestedge J; Pollock GL; Khan M; Soloczynskyj K; Fernando J; Martin GE; Caly L; Barr IG; Tran T; Druce J; Lim CK; Williamson DA
Lancet Microbe; 2024 Apr; 5(4):e317-e325. PubMed ID: 38359857
[TBL] [Abstract][Full Text] [Related]
12. Changing epidemiology of influenza and other respiratory viruses in the first year of COVID-19 pandemic.
Agca H; Akalin H; Saglik I; Hacimustafaoglu M; Celebi S; Ener B
J Infect Public Health; 2021 Sep; 14(9):1186-1190. PubMed ID: 34399190
[TBL] [Abstract][Full Text] [Related]
13. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
Mohebi L; Karami H; Mirsalehi N; Ardestani NH; Yavarian J; Mard-Soltani M; Mokhatri-Azad T; Salimi V
J Med Virol; 2022 Dec; 94(12):5802-5807. PubMed ID: 35961780
[TBL] [Abstract][Full Text] [Related]
14. Difference between SARS-CoV-2, seasonal coronavirus, influenza, and respiratory syncytial virus infection in solid organ transplant recipients.
Mendoza MA; Motoa G; Raja MA; Frattaroli P; Fernandez A; Anjan S; Courel SC; Natori A; O'Brien CB; Phancao A; Sinha N; Vianna R; Loebe M; Ciancio G; Simkins J; Abbo L; Guerra G; Natori Y
Transpl Infect Dis; 2023 Feb; 25(1):e13998. PubMed ID: 36477946
[TBL] [Abstract][Full Text] [Related]
15. Acute respiratory infection emergency access in a tertiary care children hospital in Italy, prior and after the SARS-CoV-2 emergence.
Ciofi Degli Atti M; Rizzo C; D'Amore C; Ravà L; Reale A; Barbieri MA; Bernaschi P; Russo C; Villani A; Perno CF; Raponi M
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13102. PubMed ID: 36950039
[TBL] [Abstract][Full Text] [Related]
16. Burden of primary influenza and respiratory syncytial virus pneumonia in hospitalised adults: insights from a 2-year multi-centre cohort study (2017-2018).
Boattini M; Charrier L; Almeida A; Christaki E; Moreira Marques T; Tosatto V; Bianco G; Iannaccone M; Tsiolakkis G; Karagiannis C; Maikanti P; Cruz L; Antão D; Moreira MI; Cavallo R; Costa C
Intern Med J; 2023 Mar; 53(3):404-408. PubMed ID: 34633761
[TBL] [Abstract][Full Text] [Related]
17. Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV.
Weidmann MD; Green DA; Berry GJ; Wu F
Front Cell Infect Microbiol; 2023; 13():1208235. PubMed ID: 37389220
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre.
Quarg C; Jörres RA; Engelhardt S; Alter P; Budweiser S
Eur J Med Res; 2023 Dec; 28(1):568. PubMed ID: 38053110
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
[TBL] [Abstract][Full Text] [Related]
20. Viral Pneumonia during the COVID-19 Pandemic, 2019-2021 Evoking Needs for SARS-CoV-2 and Additional Vaccinations.
Lin SC; Wang HC; Lin WC; Kuo YT; Hsu YH; Tsai YT; Lu SC; Wang YH; Chen SY
Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
